Variability in the relationship between mean plasma glucose and HbA 1c: Implications for the assessment of glycemic control

Clinical Chemistry

Volumn 53, Issue 5, 2007, Pages 897-901

  Kilpatrick, Eric S ^a   Rigby, Alan S ^b   Atkin, Stephen L ^c  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; LEAST-SQUARES ANALYSIS; MICROCIRCULATION;

EID: 34248352507     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.079756     Document Type: Article

References (22)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonyfureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. American Diabetes Association: Standards.of medical care in diabetes - 2006. Diabetes Care 2006;29:S4-42.
4. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341-6.
5. The Diabetes Control and Complications Trial Research Group. Diabetes Control and Complications Trial (DCCT). Results of feasibility study. Diabetes Care 1987;10:1-19.
6. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8.
7. Home P, Mbanya J-C, Horton E. Standardisation of glycated haemoglobin. BMJ 2004;329:1196-7.
8. 1c Assay, London, UK, January 2004. Diabetologia 2004;47:R53-4.
9. 1c. Clin Chem 2005;51:681-3.
10. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-86.
11. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-83.
12. The Diabetes Control and Complications Trial Research Group, The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-45.
13. 1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Clin Chem 2005;51:753-8.
14. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994;17:152-4.
15. Fogh-Andersen N, D'Orazio P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem 1998;44:655-9.
16. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208-15.
17. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004;27:931-5.
18. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RDG. HbA1c levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001;50:2858-63.
19. Miedema K. Towards worldwide standardisation of HbA1c determination. Diabetologia 2004;47:1143-8.
20. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat. Diabetes 2005;54:1-7.
21. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-90.
22. 1c-standardization and relationship to BG levels and complications. Diabetic Med 2006;23(Suppl 4):S17.